Bristol-Myers Squibb's merger with Celgene is done. 8 challenges ahead

Bristol-Myers Squibb's merger with Celgene is done. 8 challenges ahead

The Bristol-Celgene merger is approved. Here are 8 challenges ahead

By DAMIAN GARDE AND ADAM FEUERSTEIN

ALEX HOGAN/STAT

Here’s a look at the biggest issues facing Bristol-Myers Squibb and Celgene now that their long-awaited union has been approved by Bristol shareholders.

READ MORE